WebMainz, Germany. Mainz Biomed ( NASDAQ: MYNZ) is located just west of Frankfurt in a world-renowned community for advanced DNA & Pharmaceutical research, including the home of vaccine maker BioNTech SE. The TÜV Rheinland certifies that Mainz Biomed manufactures ColoAlert according to DIN EN ISO 13485. Click here to view certificate. WebApr 12, 2024 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Mainz Biomed stock is Buy based on the current 3 buy ratings for MYNZ. The average twelve-month price prediction for Mainz Biomed is $17.00 with a high price target of $25.00 and a low price target of $11.00. Learn more on MYNZ's analyst rating history.
About Us - Mainz Biomed
WebDie Mainz Biomed B.V. Registered Shs Aktie wird unter der ISIN NL0015000LC2 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Hamburg, Berlin, NASDAQ, Bats, … WebApr 10, 2024 · Mainz BioMed ( NASDAQ: MYNZ) – was founded in Germany and is becoming a leading global provider of easy-to-use diagnostic solutions for patients and … small portable stove top
Mainz Biomed N.V. Announces Pricing of Initial Public Offering
WebFeb 21, 2024 · Mainz Biomed is commercializing ColoAlert across Europe and in select international markets through a differentiated business model of partnering with third-party laboratories for test kit ... WebApr 6, 2024 · Das 52-Wochen-Tief (Jahres-Tiefststand) der Mainz Biomed-Aktie lag bei 5,62 Euro und war am 03.04.23. Laut aktuellem Kursniveau ist die Mainz Biomed-Aktie … WebFeb 23, 2024 · BERKELEY, Calif. and MAINZ, Germany, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the … highlights of games played yesterday